Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises KKR in the acquisition of Hyperion from Sandvik
Mandate

Vinge advises KKR in the acquisition of Hyperion from Sandvik

December 12, 2017 M&A Carve-Outs

Vinge is advising the listed US investment fund KKR on its acquisition of Hyperion, a manufacturer of industrial tool components, from Sandvik.

Hyperion has 1400 employees in a number of jurisdictions and about SEK 3.2 billion in turnover. The transaction is expected to close during the first half of 2018 and is subject to customary completion conditions such as merger filing approvals.

Vinge’s team has consisted of Christina Kokko, Kristina Ekberg, Alex Miler, Marith Welin-Berger and Matthias Pannier (M&A/Corporate), Eva Fredriksson, Mathilda Persson (TSA/IT), Tobias Kempas, Ilze Lukins, Sophia Holm (IP), Kristoffer Larson (real estate), Sara Strandberg (employment law) and Johan Cederlund and Hedvig Ekdahl (environmental).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026